Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03104361
What this trial is testing

Platelet-Rich Plasma (PRP) Injection in Treatment of Interstitial Cystitis

Who this might be right for
Interstitial Cystitis
Buddhist Tzu Chi General Hospital 30
Not applicableLooking for participantsNCT06821880
What this trial is testing

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

Who this might be right for
Chronic Lymphocytic Leukaemia (CLL)Multiple Myeloma (MM)Secondary Immunodeficiency (SID)
Medical University Innsbruck 120
Testing effectiveness (Phase 2)Ended earlyNCT00006220
What this trial is testing

Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Washington University School of Medicine 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07795073
What this trial is testing

Acceleration of Tooth Movement Using PRP and Photobiomodulation With Clear Aligners

Who this might be right for
Orthodontic Tooth Movement
Sana'a University 42
Not applicableLooking for participantsNCT06357754
What this trial is testing

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic LeukaemiaMultiple Myeloma
Bristol-Myers Squibb 50
Testing effectiveness (Phase 2)Study completedNCT02213913
What this trial is testing

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Diffuse Large Cell Lymphoma+69 more
University of Chicago 55
Early research (Phase 1)Study completedNCT02274623
What this trial is testing

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

Who this might be right for
Breast CancerProstate CancerBone Neoplasms+2 more
OPKO Health, Inc. 33
Testing effectiveness (Phase 2)Looking for participantsNCT07681596
What this trial is testing

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
AstraZeneca 101
Testing effectiveness (Phase 2)Study completedNCT00112827
What this trial is testing

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaSmoldering Multiple MyelomaStage I Multiple Myeloma+2 more
City of Hope Medical Center 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07090954
What this trial is testing

GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 32
Large-scale testing (Phase 3)Ended earlyNCT00089141
What this trial is testing

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Cancer
Martin, Paul 151
Not applicableStudy completedNCT05260203
What this trial is testing

MargheRITA (Remote Intelligence for Therapeutic Adherence)

Who this might be right for
Multiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more
Advice Pharma Group srl 124
Early research (Phase 1)UnknownNCT01843686
What this trial is testing

Using Autologous Platelet Rich Plasma (PRP) Gel to Treat Deep 2nd and 3rd Degree Burns

Who this might be right for
Acute Burns
Arteriocyte, Inc. 42
Testing effectiveness (Phase 2)Looking for participantsNCT05628922
What this trial is testing

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

Who this might be right for
Nasopharyngeal Cancer
Fudan University 198
Not applicableStudy completedNCT03044431
What this trial is testing

Autologous Stem Cell Treatment for Chronic Lung Disease Study

Who this might be right for
COPDInterstitial Lung Disease
Lung Institute 207
Early research (Phase 1)Study completedNCT04869072
What this trial is testing

Convalescent Plasma Therapy - Zurich Protocol

Who this might be right for
COVID-19
University of Zurich 30
Early research (Phase 1)Study completedNCT01582295
What this trial is testing

XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 4
Not applicableStudy completedNCT03716141
What this trial is testing

Autologous Platelets Rich Plasma (APRP) Treatment Vs Saline Dressing for the Management of Diabetic Foot Ulcer

Who this might be right for
Diabetic Foot Ulcer
Services Hospital, Lahore 100
Early research (Phase 1)Looking for participantsNCT07250269
What this trial is testing

Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis

Who this might be right for
Relapsed/Refractory AL Amyloidosis
Gracell Biotechnologies (Shanghai) Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT00095277
What this trial is testing

Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer

Who this might be right for
Anemia
Amgen 220
Next Page